Literature DB >> 18612373

A Study of Methadone Maintenance For Male Prisoners: 3-Month Postrelease Outcomes.

Timothy W Kinlock1, Michael S Gordon, Robert P Schwartz, Kevin E O'Grady.   

Abstract

This study examined benefits of methadone maintenance among prerelease prison inmates. Incarcerated males with preincarceration heroin dependence (n = 197) were randomly assigned to (a) group educational counseling (counseling only); (b) counseling, with opportunity to begin methadone maintenance on release (counseling + transfer); or (c) counseling and methadone maintenance in prison, with opportunity to continue methadone maintenance on release (counseling + methadone). At 90-day follow-up, counseling + methadone participants were significantly more likely than counseling-only and counseling + transfer participants to attend drug treatment (p = .0001) and less likely to be reincarcerated (p = .019). Counseling + methadone and counseling + transfer participants were significantly less likely (all ps < .05) to report heroin use, cocaine use, and criminal involvement than counseling-only participants. Follow-up is needed to determine whether these findings hold over a longer period.

Entities:  

Year:  2008        PMID: 18612373      PMCID: PMC2443939          DOI: 10.1177/0093854807309111

Source DB:  PubMed          Journal:  Crim Justice Behav        ISSN: 0093-8548


  19 in total

1.  Attitudes and practices regarding the use of methadone in US state and federal prisons.

Authors:  Josiah D Rich; Amy E Boutwell; David C Shield; R Garrett Key; Michelle McKenzie; Jennifer G Clarke; Peter D Friedmann
Journal:  J Urban Health       Date:  2005-05-25       Impact factor: 3.671

Review 2.  Prevention and treatment of hepatitis C in injection drug users.

Authors:  Brian R Edlin
Journal:  Hepatology       Date:  2002-11       Impact factor: 17.425

3.  Linkage with methadone treatment upon release from incarceration: a promising opportunity.

Authors:  Josiah D Rich; Michelle McKenzie; David C Shield; Francis A Wolf; R Garrett Key; Michael Poshkus; Jennifer Clarke
Journal:  J Addict Dis       Date:  2005

4.  Methadone treatment of randomly selected criminal addicts.

Authors:  V P Dole; J W Robinson; J Orraca; E Towns; P Searcy; E Caine
Journal:  N Engl J Med       Date:  1969-06-19       Impact factor: 91.245

5.  A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence.

Authors:  R E Johnson; M A Chutuape; E C Strain; S L Walsh; M L Stitzer; G E Bigelow
Journal:  N Engl J Med       Date:  2000-11-02       Impact factor: 91.245

6.  A novel opioid maintenance program for prisoners: report of post-release outcomes.

Authors:  Timothy W Kinlock; Robert J Battjes; Robert P Schwartz
Journal:  Am J Drug Alcohol Abuse       Date:  2005       Impact factor: 3.829

Review 7.  Methadone maintenance treatment (MMT): a review of historical and clinical issues.

Authors:  H Joseph; S Stancliff; J Langrod
Journal:  Mt Sinai J Med       Date:  2000 Oct-Nov

8.  A long-term program of research on drug use and crime.

Authors:  D N Nurco
Journal:  Subst Use Misuse       Date:  1998-07       Impact factor: 2.164

Review 9.  The nature and status of drug abuse treatment.

Authors:  D N Nurco; T W Kinlock; T E Hanlon
Journal:  Md Med J       Date:  1994-01

10.  Pre- and in-treatment predictors of retention in methadone treatment using survival analysis.

Authors:  S Magura; P C Nwakeze; S Y Demsky
Journal:  Addiction       Date:  1998-01       Impact factor: 6.526

View more
  41 in total

1.  Improving access to opiate addiction treatment for prisoners.

Authors:  Amy Nunn; Nickolas Zaller; Samuel Dickman; Ank Nijhawan; Josiah D Rich
Journal:  Addiction       Date:  2010-07       Impact factor: 6.526

Review 2.  Opportunities to diagnose, treat, and prevent HIV in the criminal justice system.

Authors:  Curt G Beckwith; Nickolas D Zaller; Jeannia J Fu; Brian T Montague; Josiah D Rich
Journal:  J Acquir Immune Defic Syndr       Date:  2010-12       Impact factor: 3.731

3.  Improving healthcare for incarcerated women.

Authors:  Sandra A Springer
Journal:  J Womens Health (Larchmt)       Date:  2010-01       Impact factor: 2.681

4.  Forced withdrawal from methadone maintenance therapy in criminal justice settings: a critical treatment barrier in the United States.

Authors:  Jeannia J Fu; Nickolas D Zaller; Michael A Yokell; Alexander R Bazazi; Josiah D Rich
Journal:  J Subst Abuse Treat       Date:  2013-02-22

5.  A Randomized Clinical Trial of Methadone Maintenance for Prisoners: Prediction of Treatment Entry and Completion in Prison.

Authors:  Michael S Gordon; Timothy W Kinlock; Kathryn A Couvillion; Robert P Schwartz; Kevin O'Grady
Journal:  J Offender Rehabil       Date:  2012-05-01

6.  A randomized trial of methadone initiation prior to release from incarceration.

Authors:  Michelle McKenzie; Nickolas Zaller; Samuel L Dickman; Traci C Green; Amisha Parihk; Peter D Friedmann; Josiah D Rich
Journal:  Subst Abus       Date:  2012       Impact factor: 3.716

7.  Treating drug abuse and addiction in the criminal justice system: improving public health and safety.

Authors:  Redonna K Chandler; Bennett W Fletcher; Nora D Volkow
Journal:  JAMA       Date:  2009-01-14       Impact factor: 56.272

8.  A randomized clinical trial of methadone maintenance for prisoners: findings at 6 months post-release.

Authors:  Michael S Gordon; Timothy W Kinlock; Robert P Schwartz; Kevin E O'Grady
Journal:  Addiction       Date:  2008-08       Impact factor: 6.526

9.  Improved HIV and substance abuse treatment outcomes for released HIV-infected prisoners: the impact of buprenorphine treatment.

Authors:  Sandra Ann Springer; Shu Chen; Frederick L Altice
Journal:  J Urban Health       Date:  2010-07       Impact factor: 3.671

10.  Methadone and buprenorphine prescribing and referral practices in US prison systems: results from a nationwide survey.

Authors:  Amy Nunn; Nickolas Zaller; Samuel Dickman; Catherine Trimbur; Ank Nijhawan; Josiah D Rich
Journal:  Drug Alcohol Depend       Date:  2009-07-21       Impact factor: 4.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.